Following are forecasted sales, NOPAT, and NOA for Colgate-Palmolive Company for 2019 through 2022.

		Forecast Horizon Period
Colgate Palmolive (CL)	Reported
$ millions	2018	2019	2020	2021	2022
Sales	$15,699	$16,170	$16,656	$17,155	$17,670
NOPAT	2,764	2,846	2,931	3,019	3,110
NOA	5,895	6,072	6,255	6,442	6,636

Required a. Forecast the terminal period values assuming a 1% terminal period growth for all three model inputs, that is Sales, NOPAT, and NOA. Note: Round your answers to the nearest whole dollar. Sales $Answer NOPAT $Answer NOA $Answer b. Estimate the value of a share of Colgate-Palmolive common stock using the discounted cash flow (DCF) model; assume a discount rate (WACC) of 5.7%, common shares outstanding of 862.9 million, net nonoperating obligations (NNO) of $5,696 million, and noncontrolling interest (NCI) from the balance sheet of $302 million. Note: Round your final answer to two decimal places (for example, round $15.555 to $15.56). Stock price per share: $Answer c. Colgate-Palmolives stock closed at $67.37 on February 21, 2019, the date the Form 10-K was filed with the SEC. How does your valuation estimate compare with this closing price? AnswerStock price is overvaluedStock price is undervaluedStock price is appropriately valued d. The forecasts you completed assumed a terminal growth rate of 1%. What if the terminal rate had been 2%. What would your estimated stock price have been? Note: Round your final answer to two decimal places (for example, round $15.555 to $15.56). Stock price per share: $Answer e. What would WACC have to be to warrant the actual stock price on February 21, 2019? Note: Round percentage to two decimal places (for example, round 15.555% to 15.56%). WACC Answer%